RxDoctor Payments Data

Melvin Melendez Rios, MD

Gastroenterology · San Juan, PRNPI 1164531059

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.1% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by AbbVie at 34.6% of the total. That places this record below the midpoint for gastroenterology clinicians in PR, where the typical reported total is $1,676.

$1,368in general payments, 2019–2025

Across 30 payments — averaging $45.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$474
  • E.r. Squibb & Sons, L.L.C.$342
  • Johnson & Johnson$167
  • Albireo Pharma, Inc.$122
  • PBG Puerto Rico LLC$110
  • Merck$72
  • plus $82 from 2 others
$133,122in research payments, 2019–2025

Across 66 payments — averaging $2017.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$109K
  • AstraZeneca$24K

What the payments were for

  • Food & beverage$1,30195%
  • Education$675%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie13$474
E.r. Squibb & Sons, L.L.C.4$342
Johnson & Johnson(2 entities)2$167
Albireo Pharma, Inc.1$122
PBG Puerto Rico LLC5$110
Merck1$72
Gilead3$52
Madrigal Pharmaceuticals1$31

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,368 in reported general payments places this provider in the 45th percentile of 198 gastroenterology providers in Puerto Rico.

See all gastroenterology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$9,882
Medicare patients
23
Services billed
61

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mesalamine DrMesalamine28$6,695
Mesalamine12$5,441
Ursodiol26$3,968
Sucralfate44$2,741
Famotidine266$1,911
Omeprazole166$870
Fentanyl CitrateFentanyl Citrate/Pf181$621
Sulfasalazine14$592
Midazolam Hcl176$512
Clarithromycin17$492
Midazolam HclMidazolam Hcl/Pf158$470
Pantoprazole Sodium49$365
Lansoprazole26$325
Amoxicillin16$218

Paid to pharmacies, not to this prescriber.

Other gastroenterology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →